It's been proved time and time again that buying for the long haul outperforms short-term investing. It's also been shown that investing in dividend-paying stocks can produce higher returns than investing in non-dividend-paying stocks. However, not all dividend-paying stocks are created equal. For instance, here are two dividend stocks that I think are worth avoiding and one that I think can be owned for the long haul.
Patent expiration will remain the biggest risk to dividend-paying stocks in healthcare, and that's particularly true for PDL Biopharma's (NASDAQ: PDLI) and Amgen's (NASDAQ: AMGN). Both of those companies are taking steps to ensure that sales growth doesn't sputter and put dividend payouts in jeopardy. But neither offers the kind of clarity that most dividend investors require to make them part of an income portfolio. That suggests that a better bet is to own Gilead Sciences (NASDAQ: GILD). Gilead Sciences' top sellers have plenty of patent protection, and it has a rock-solid balance sheet that could mean its dividend is both safe and likely to grow.
Source: Motley Fool
Related Articles:
- Are Defense Stocks Good Defensive Stocks?
- International Securities For A Diversified Income Portfolio
- 5 Dividend Stocks That Gave Me A 20%+ Annualized Return
- 6 Rainy Day Dividend Stocks
- When A Stock Fails To Raise Its Dividend: Is It Time To Sell Intel?
________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
Showing resilience during a tough week was a group of stocks that has not been heard from much in the past two years. A group that has been ...
-
While these pharma stocks have steady cash flows and revenues, there’s still plenty of growth left in the tank from new drugs in development...
-
Do you ever wish your dividend stocks paid out monthly rather than quarterly? For income-oriented investors who cover their monthly expenses...
-
This company is one of the less risky mortgage REITs. We see preferred shares from it as having a risk rating of 2. The series C shares drop...
-
In bull markets, dividends become more or less irrelevant. When the Dow Jones Industrial Average traded above 14,000 in 2007, very few stoc...
-
Insiders bought 45,000 units last week: It's now at multi-year lows, and is 26% below analysts' lowest price target, and is selling ...
-
After prices rising for nearly two straight years, volatility has returned to the oil patch in the past month. Investors can expect above-av...
-
Despite a strong year, the renewable power company has lost 20% of its value, which has pushed its dividend yield up to 7%. That lower price...
-
Add it all up, and things are starting to get tense. That leaves investors wondering where they can go for safety. After years of tech outpe...
-
The yield is 9.55%, with 1.12X coverage that should improve in 2019. Management has raised the quarterly distribution 16 straight quarters. ...
0 comments
Post a Comment
Post a Comment